Objectives : The objective was to define the characteristics of a real-world patient population
treated with transcatheter aortic valve implantation (TAVI), regardless of technology or …

Background— Transcatheter aortic valve implantation was developed to mitigate the mortality
and morbidity associated with high-risk traditional aortic valve replacement. The Edwards …

Background— The optimal strategy for treating coronary bifurcation lesions remains a
subject of debate. With bare-metal stents, single-stent approaches appear to be superior to …

Background— Transcatheter aortic valve implantation was developed to provide a therapeutic
option for patients considered to be ineligible for, and to mitigate mortality and morbidity …

Background Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic
option in high-risk patients with severe aortic stenosis. Aims PARTNER EU is the first …

Context Observational studies have previously reported that elective intra-aortic balloon
pump (IABP) insertion may improve outcomes following high-risk percutaneous coronary …

Background: Percutaneous coronary intervention (PCI) of coronary bifurcation lesions
remains a subject of debate. Many studies have been published in this setting. They are often …

Background : The SAPIEN 3 (Edwards Lifesciences Inc., Irvine, California) transcatheter
valve incorporates features designed to address the well-known deficiencies of transcatheter …

The focus of Software for Dependable Systems is a set of fundamental principles that underlie
software system dependability and that suggest a different approach to the development …

Background— Aim of this trial was to compare rotational atherectomy followed by balloon
angioplasty (rotablation [ROTA] group) with balloon angioplasty (percutaneous transluminal …